Skip to main content
Erschienen in: Anatomical Science International 2/2020

10.12.2019 | Original Article

Effects of phosphorylated estrogen receptor alpha on apoptosis in human endometrial epithelial cells

verfasst von: Shunsuke Uchida, Mierxiati Saimi, Zhong-Lian Li, Hidenobu Miyaso, Kenta Nagahori, Shinichi Kawata, Takuya Omotehara, Yuki Ogawa, Masahiro Itoh

Erschienen in: Anatomical Science International | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

It is known that the activities of estrogen receptor α (ERα) can be modulated by epidermal growth factor (EGF) through the phosphatidylinostitol 3-kinase-alpha serine/threonine protein kinase (PI3K-AKT) pathway by phosphorylation. To clarify how ERα functions are regulated in endometrial cells during menstrual cycle, molecules related to phosphorylation of ERα (pERα) were examined. It was found that the expression of phosphorylated AKT on serine 473 (pAKT-Ser473) was increased during the proliferative phase, but decreased in the secretory phase. Although the expression of pAKT on threonine 308 in the proliferative phase was only identified in the wall of arterioles, it was strongly expressed in the cytoplasm of endometrial glandular cells after entering the secretory phase. Further observations revealed that while the expression of pERα-Ser104 was constant, pERα-Ser118 was expressed following a cyclic pattern similar to that of the pAKT-Ser473. Following treatment with specific inhibitors for EGFR-PI3K-AKT pathway, it was found that while the expression of pERα-Ser118 and pERα-Ser167 was inhibited, the induced apoptosis could be antagonized by the addition of estrogen, indicating that a mitochondrial pathway is involved. Therefore, pAKT and pERα or ERα could act cooperatively on coiled arterioles and endometrial cells in order to control menstrual cycle.
Literatur
Zurück zum Zitat Abe H, Shibata MA, Otsuki Y (2006) Caspase cascade of Fas-mediated apoptosis in human normal endometrium and endometrial carcinoma cells. Mol Hum Reprod 12:535–541PubMedCrossRef Abe H, Shibata MA, Otsuki Y (2006) Caspase cascade of Fas-mediated apoptosis in human normal endometrium and endometrial carcinoma cells. Mol Hum Reprod 12:535–541PubMedCrossRef
Zurück zum Zitat Al-Dhaheri MH, Rowan BG (2006) Application of phosphorylation site-specific antibodies to measure nuclear receptor signaling: characterization of novel phosphoantibodies for estrogen receptor alpha. Nucl Recept Signal 4:e007PubMedPubMedCentralCrossRef Al-Dhaheri MH, Rowan BG (2006) Application of phosphorylation site-specific antibodies to measure nuclear receptor signaling: characterization of novel phosphoantibodies for estrogen receptor alpha. Nucl Recept Signal 4:e007PubMedPubMedCentralCrossRef
Zurück zum Zitat Arnold SF, Obourn JD, Jaffe H, Notides AC (1995) Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding. J Steroid Biochem Mol Biol 55:163–172PubMedCrossRef Arnold SF, Obourn JD, Jaffe H, Notides AC (1995) Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding. J Steroid Biochem Mol Biol 55:163–172PubMedCrossRef
Zurück zum Zitat Baranda-Avila N, Mendoza-Rodriguez CA, Morimoto S, Camacho-Arroyo I, Guerra-Araiza C, Langley E, Cerbon M (2013) Agonistic activity of ICI 182 780 on activation of GSK 3beta/AKT pathway in the rat uterus during the estrous cycle. Steroids 78:717–725PubMedCrossRef Baranda-Avila N, Mendoza-Rodriguez CA, Morimoto S, Camacho-Arroyo I, Guerra-Araiza C, Langley E, Cerbon M (2013) Agonistic activity of ICI 182 780 on activation of GSK 3beta/AKT pathway in the rat uterus during the estrous cycle. Steroids 78:717–725PubMedCrossRef
Zurück zum Zitat Bartelmez GW (1956) Premenstrual and menstrual ischemia and the myth of endometrial arteriovenous anastomoses. Am J Anat 98:69–95PubMedCrossRef Bartelmez GW (1956) Premenstrual and menstrual ischemia and the myth of endometrial arteriovenous anastomoses. Am J Anat 98:69–95PubMedCrossRef
Zurück zum Zitat Brasseur K, Gevry N, Asselin E (2017) Chemoresistance and targeted therapies in ovarian and endometrial cancers. Oncotarget 8:4008–4042PubMedCrossRef Brasseur K, Gevry N, Asselin E (2017) Chemoresistance and targeted therapies in ovarian and endometrial cancers. Oncotarget 8:4008–4042PubMedCrossRef
Zurück zum Zitat Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H (2001) Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem 276:9817–9824PubMedCrossRef Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H (2001) Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem 276:9817–9824PubMedCrossRef
Zurück zum Zitat Fanger H, Barker BE (1961) Capillaries and arterioles in normal endometrium. Obstet Gynecol 17:543–550PubMed Fanger H, Barker BE (1961) Capillaries and arterioles in normal endometrium. Obstet Gynecol 17:543–550PubMed
Zurück zum Zitat Ferenczy A, Bertrand G, Gelfand MM (1979) Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 133:859–867PubMedCrossRef Ferenczy A, Bertrand G, Gelfand MM (1979) Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 133:859–867PubMedCrossRef
Zurück zum Zitat Guzeloglu Kayisli O, Kayisli UA, Luleci G, Arici A (2004) In vivo and in vitro regulation of Akt activation in human endometrial cells is estrogen dependent. Biol Reprod 71:714–721PubMedCrossRef Guzeloglu Kayisli O, Kayisli UA, Luleci G, Arici A (2004) In vivo and in vitro regulation of Akt activation in human endometrial cells is estrogen dependent. Biol Reprod 71:714–721PubMedCrossRef
Zurück zum Zitat Hermon TL, Moore AB, Yu L, Kissling GE, Castora FJ, Dixon D (2008) Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium. Virchows Arch 453:557–569PubMedPubMedCentralCrossRef Hermon TL, Moore AB, Yu L, Kissling GE, Castora FJ, Dixon D (2008) Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium. Virchows Arch 453:557–569PubMedPubMedCentralCrossRef
Zurück zum Zitat Hopwood D, Levison DA (1976) Atrophy and apoptosis in the cyclical human endometrium. J Pathol 119:159–166PubMedCrossRef Hopwood D, Levison DA (1976) Atrophy and apoptosis in the cyclical human endometrium. J Pathol 119:159–166PubMedCrossRef
Zurück zum Zitat Joel PB, Traish AM, Lannigan DA (1998) Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem 273:13317–13323PubMedCrossRef Joel PB, Traish AM, Lannigan DA (1998) Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. J Biol Chem 273:13317–13323PubMedCrossRef
Zurück zum Zitat Kato S, Kitamoto T, Masuhiro Y, Yanagisawa J (1998) Molecular mechanism of a cross-talk between estrogen and growth-factor signaling pathways. Oncology 55(Suppl 1):5–10PubMedCrossRef Kato S, Kitamoto T, Masuhiro Y, Yanagisawa J (1998) Molecular mechanism of a cross-talk between estrogen and growth-factor signaling pathways. Oncology 55(Suppl 1):5–10PubMedCrossRef
Zurück zum Zitat Kato E, Orisaka M, Kurokawa T, Chino Y, Fujita Y, Shinagawa A, Yoshida Y (2014) Relation between outcomes and expression of estrogen receptor-alpha phosphorylated at Ser(167) in endometrioid endometrial cancer. Cancer Sci 105:1307–1312PubMedPubMedCentralCrossRef Kato E, Orisaka M, Kurokawa T, Chino Y, Fujita Y, Shinagawa A, Yoshida Y (2014) Relation between outcomes and expression of estrogen receptor-alpha phosphorylated at Ser(167) in endometrioid endometrial cancer. Cancer Sci 105:1307–1312PubMedPubMedCentralCrossRef
Zurück zum Zitat Kazi AA, Molitoris KH, Koos RD (2009) Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus. Biol Reprod 81:378–387PubMedPubMedCentralCrossRef Kazi AA, Molitoris KH, Koos RD (2009) Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus. Biol Reprod 81:378–387PubMedPubMedCentralCrossRef
Zurück zum Zitat Kokawa K, Shikone T, Nakano R (1996) Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab 81:4144–4147PubMed Kokawa K, Shikone T, Nakano R (1996) Apoptosis in the human uterine endometrium during the menstrual cycle. J Clin Endocrinol Metab 81:4144–4147PubMed
Zurück zum Zitat Le AW, Shan LL, Dai XY, Xiao TH, Li XR, Wang ZH, Zhang J, Chen XY (2016) PI3K, AKT, and P-AKT levels in thin endometrium. Genet Mol Res 15:10CrossRef Le AW, Shan LL, Dai XY, Xiao TH, Li XR, Wang ZH, Zhang J, Chen XY (2016) PI3K, AKT, and P-AKT levels in thin endometrium. Genet Mol Res 15:10CrossRef
Zurück zum Zitat Lecce G, Meduri G, Ancelin M, Bergeron C, Perrot-Applanat M (2001) Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metab 86:1379–1386PubMed Lecce G, Meduri G, Ancelin M, Bergeron C, Perrot-Applanat M (2001) Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metab 86:1379–1386PubMed
Zurück zum Zitat Levin ER (2001) Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol 91:1860–1867PubMedCrossRef Levin ER (2001) Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol 91:1860–1867PubMedCrossRef
Zurück zum Zitat Li ZL, Abe H, Ueki K, Kumagai K, Araki R, Otsuki Y (2003) Identification of c-Jun as bcl-2 transcription factor in human uterine endometrium. J Histochem Cytochem 51:1601–1609PubMedCrossRef Li ZL, Abe H, Ueki K, Kumagai K, Araki R, Otsuki Y (2003) Identification of c-Jun as bcl-2 transcription factor in human uterine endometrium. J Histochem Cytochem 51:1601–1609PubMedCrossRef
Zurück zum Zitat Li ZL, Morishima S, Tang JT, Otsuki Y (2009) Apoptotic effects of Tian-Long compound on endometrial adenocarcinoma cells in vitro. Med Mol Morphol 42:32–39PubMedCrossRef Li ZL, Morishima S, Tang JT, Otsuki Y (2009) Apoptotic effects of Tian-Long compound on endometrial adenocarcinoma cells in vitro. Med Mol Morphol 42:32–39PubMedCrossRef
Zurück zum Zitat Li ZL, Ueki K, Kumagai K, Araki R, Otsuki Y (2014) Regulation of bcl-2 transcription by estrogen receptor-alpha and c-Jun in human endometrium. Med Mol Morphol 47:43–53PubMedCrossRef Li ZL, Ueki K, Kumagai K, Araki R, Otsuki Y (2014) Regulation of bcl-2 transcription by estrogen receptor-alpha and c-Jun in human endometrium. Med Mol Morphol 47:43–53PubMedCrossRef
Zurück zum Zitat Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE, Stoica A (2000) A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141:4503–4511PubMedCrossRef Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE, Stoica A (2000) A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141:4503–4511PubMedCrossRef
Zurück zum Zitat Meier R, Alessi DR, Cron P, Andjelkovic M, Hemmings BA (1997) Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta. J Biol Chem 272:30491–30497PubMedCrossRef Meier R, Alessi DR, Cron P, Andjelkovic M, Hemmings BA (1997) Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta. J Biol Chem 272:30491–30497PubMedCrossRef
Zurück zum Zitat Miller TW, Rexer BN, Garrett JT, Arteaga CL (2011) Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. Breast Cancer Res 13:224PubMedPubMedCentralCrossRef Miller TW, Rexer BN, Garrett JT, Arteaga CL (2011) Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. Breast Cancer Res 13:224PubMedPubMedCentralCrossRef
Zurück zum Zitat Mundi PS, Sachdev J, McCourt C, Kalinsky K (2016) AKT in cancer: new molecular insights and advances in drug development. Br J Clin Pharmacol 82:943–956PubMedPubMedCentralCrossRef Mundi PS, Sachdev J, McCourt C, Kalinsky K (2016) AKT in cancer: new molecular insights and advances in drug development. Br J Clin Pharmacol 82:943–956PubMedPubMedCentralCrossRef
Zurück zum Zitat Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14:381–395PubMedCrossRef Nicholson KM, Anderson NG (2002) The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14:381–395PubMedCrossRef
Zurück zum Zitat Rogers PA, Lederman F, Kooy J, Taylor NH, Healy DL (1996) Endometrial vascular smooth muscle oestrogen and progesterone receptor distribution in women with and without menorrhagia. Hum Reprod 11:2003–2008PubMedCrossRef Rogers PA, Lederman F, Kooy J, Taylor NH, Healy DL (1996) Endometrial vascular smooth muscle oestrogen and progesterone receptor distribution in women with and without menorrhagia. Hum Reprod 11:2003–2008PubMedCrossRef
Zurück zum Zitat Salvesen HB, Carter SL, Mannelqvist M, Dutt A, Getz G, Stefansson IM, Raeder MB, Sos ML, Engelsen IB, Trovik J, Wik E, Greulich H, Bo TH, Jonassen I, Thomas RK, Zander T, Garraway LA, Oyan AM, Sellers WR, Kalland KH, Meyerson M, Akslen LA, Beroukhim R (2009) Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proc Natl Acad Sci USA 106:4834–4839PubMedPubMedCentralCrossRef Salvesen HB, Carter SL, Mannelqvist M, Dutt A, Getz G, Stefansson IM, Raeder MB, Sos ML, Engelsen IB, Trovik J, Wik E, Greulich H, Bo TH, Jonassen I, Thomas RK, Zander T, Garraway LA, Oyan AM, Sellers WR, Kalland KH, Meyerson M, Akslen LA, Beroukhim R (2009) Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proc Natl Acad Sci USA 106:4834–4839PubMedPubMedCentralCrossRef
Zurück zum Zitat Scheid MP, Woodgett JR (2001) PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2:760–768PubMedCrossRef Scheid MP, Woodgett JR (2001) PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2:760–768PubMedCrossRef
Zurück zum Zitat Shah YM, Rowan BG (2005) The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity. Mol Endocrinol 19:732–748PubMedCrossRef Shah YM, Rowan BG (2005) The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity. Mol Endocrinol 19:732–748PubMedCrossRef
Zurück zum Zitat Stoica GE, Franke TF, Moroni M, Mueller S, Morgan E, Iann MC, Winder AD, Reiter R, Wellstein A, Martin MB, Stoica A (2003) Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene 22:7998–8011PubMedCrossRef Stoica GE, Franke TF, Moroni M, Mueller S, Morgan E, Iann MC, Winder AD, Reiter R, Wellstein A, Martin MB, Stoica A (2003) Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene 22:7998–8011PubMedCrossRef
Zurück zum Zitat Strissel PL, Ellmann S, Loprich E, Thiel F, Fasching PA, Stiegler E, Hartmann A, Beckmann MW, Strick R (2008) Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen. Int J Cancer 123:2871–2879PubMedCrossRef Strissel PL, Ellmann S, Loprich E, Thiel F, Fasching PA, Stiegler E, Hartmann A, Beckmann MW, Strick R (2008) Early aberrant insulin-like growth factor signaling in the progression to endometrial carcinoma is augmented by tamoxifen. Int J Cancer 123:2871–2879PubMedCrossRef
Zurück zum Zitat Thomas G, Hall MN (1997) TOR signalling and control of cell growth. Curr Opin Cell Biol 9:782–787PubMedCrossRef Thomas G, Hall MN (1997) TOR signalling and control of cell growth. Curr Opin Cell Biol 9:782–787PubMedCrossRef
Zurück zum Zitat Toyofuku A, Hara T, Taguchi T, Katsura Y, Ohama K, Kudo Y (2006) Cyclic and characteristic expression of phosphorylated Akt in human endometrium and decidual cells in vivo and in vitro. Hum Reprod 21:1122–1128PubMedCrossRef Toyofuku A, Hara T, Taguchi T, Katsura Y, Ohama K, Kudo Y (2006) Cyclic and characteristic expression of phosphorylated Akt in human endometrium and decidual cells in vivo and in vitro. Hum Reprod 21:1122–1128PubMedCrossRef
Zurück zum Zitat Veillette A, Grenier K, Brasseur K, Frechette-Frigon G, Leblanc V, Parent S, Asselin E (2013) Regulation of the PI3-K/Akt survival pathway in the rat endometrium. Biol Reprod 88:79PubMedCrossRef Veillette A, Grenier K, Brasseur K, Frechette-Frigon G, Leblanc V, Parent S, Asselin E (2013) Regulation of the PI3-K/Akt survival pathway in the rat endometrium. Biol Reprod 88:79PubMedCrossRef
Zurück zum Zitat Vilgelm A, Lian Z, Wang H, Beauparlant SL, Klein-Szanto A, Ellenson LH, Di Cristofano A (2006) Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice. Cancer Res 66:3375–3380PubMedCrossRef Vilgelm A, Lian Z, Wang H, Beauparlant SL, Klein-Szanto A, Ellenson LH, Di Cristofano A (2006) Akt-mediated phosphorylation and activation of estrogen receptor alpha is required for endometrial neoplastic transformation in Pten+/- mice. Cancer Res 66:3375–3380PubMedCrossRef
Zurück zum Zitat von Rango U, Classen-Linke I, Krusche CA, Beier HM (1998) The receptive endometrium is characterized by apoptosis in the glands. Hum Reprod 13:3177–3189CrossRef von Rango U, Classen-Linke I, Krusche CA, Beier HM (1998) The receptive endometrium is characterized by apoptosis in the glands. Hum Reprod 13:3177–3189CrossRef
Zurück zum Zitat Williams CC, Basu A, El-Gharbawy A, Carrier LM, Smith CL, Rowan BG (2009) Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2. BMC Biochem 10:36PubMedPubMedCentralCrossRef Williams CC, Basu A, El-Gharbawy A, Carrier LM, Smith CL, Rowan BG (2009) Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2. BMC Biochem 10:36PubMedPubMedCentralCrossRef
Zurück zum Zitat Yamashita H, Nishio M, Kobayashi S, Ando Y, Sugiura H, Zhang Z, Hamaguchi M, Mita K, Fujii Y, Iwase H (2005) Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer. Breast Cancer Res 7:R753–764PubMedPubMedCentralCrossRef Yamashita H, Nishio M, Kobayashi S, Ando Y, Sugiura H, Zhang Z, Hamaguchi M, Mita K, Fujii Y, Iwase H (2005) Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer. Breast Cancer Res 7:R753–764PubMedPubMedCentralCrossRef
Metadaten
Titel
Effects of phosphorylated estrogen receptor alpha on apoptosis in human endometrial epithelial cells
verfasst von
Shunsuke Uchida
Mierxiati Saimi
Zhong-Lian Li
Hidenobu Miyaso
Kenta Nagahori
Shinichi Kawata
Takuya Omotehara
Yuki Ogawa
Masahiro Itoh
Publikationsdatum
10.12.2019
Verlag
Springer Singapore
Erschienen in
Anatomical Science International / Ausgabe 2/2020
Print ISSN: 1447-6959
Elektronische ISSN: 1447-073X
DOI
https://doi.org/10.1007/s12565-019-00515-0

Weitere Artikel der Ausgabe 2/2020

Anatomical Science International 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.